Abstract:A potent drug candidature of two new copper (II) complexes have been synthesized and characterized by CHN analysis, FTIR, ESI‐MS and XRD techniques. The complexes have been analyzed biomolecular interactions by spectroscopic methods. Furthermore, radical scavenging and antiproliferative activities of the complexes were also investigated. [Cu(5‐ClSal‐Trp)(bpy)]·CH3OH (1) and [Cu(3,5‐ClSal‐Trp)(bpy)]·H2O (2) (5‐ClSal‐Trp: Schiff base derived from 5‐chlorosalicylaldehyde and tryptophan, 3,5‐ClSal‐Trp: Schiff base derived from 3,5‐dichlorosalicylaldehyde and tryptophan, bpy: 2,2′‐bipyridine) have been synthesized and analyzed by CHN analysis, FTIR, electronic absorption spectroscopy, ESI‐MS and XRD techniques. Interaction of the complexes with biomolecules {calf thymus DNA (CT‐DNA) and bovine serum albumin (BSA)} has been researched by fluorescence and electronic absorption spectroscopy. The results show that the complexes can bind via a moderate intercalation binding mode. According to the results obtained with both methods, the logKb and logKSV values of the complexes were found to be very close to each other. BSA quenching mechanism was found to be static. The results showed that the interaction between the complexes and BSA is driven by the hydrogen bond and van der Waals interaction. Additionally, the r values of the complexes (the complex 1 = 0.59 nm and the complex 2 = 0.53 nm) calculated from FRET theory suggested that the distance between the complexes (acceptor) and BSA (donor) is quite close. The complexes exhibited free radical scavenging activity compared to the standard antioxidant β‐carotene and catechin. Antiproliferative efficiency of the complexes on both breast cancer cells (MCF‐7 and MDA‐MB‐231) were also researched using the Sulforhodamine B (SRB) viability assay. It was found that the complex 1 (IC50 = 10.99 μM) exhibited higher cytotoxicity than cisplatin (IC50 = 15.6 μM) against MDA‐MB‐231 cell line. Additionally, intracellular reactive oxygen species (ROS) formation was determined by dihydroethidium (DHE) fluorescent staining. N‐acetylcysteine (NAC) was used as an efficient reactive oxygen species (ROS) scavenger. It was observed that newly synthesized Cu (II) complexes exhibited anti‐growth potential in human breast cancer cells. Additionally, it was determined that the complexes induced reactive oxygen species (ROS) formation in cells in a dose‐dependent manner.

Dichloro-bis(theophylline)-copper(II) complex: Characterization of the physicochemical, computational pharmacokinetics, molecular docking, and cytotoxicity as potential antitumoral medicine

Synthesis, electronic and vibrational properties, solvation effects, ADME and cytotoxic assay of aqua-(1,10-phenanthroline)-tyrosinato-copper(II) nitrate dihydrate complex: experimental and theoretical studies

Copper(II) Complexes with 2,2':6',2′′-Terpyridine Derivatives Displaying Dimeric Dichloro-μ-Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models

Synthesis and structure elucidation of new μ-oxamido-bridged dicopper(II) complex with in vitro anticancer activity: A combined study from experiment verification and docking calculation on DNA/protein-binding property.

Syntheses and Crystal Structures of Tetracopper(Ii) Complexes Bridged by Asymmetric N,N '-Bis(substituted)oxamides: Molecular Docking, Dna-Binding and in Vitro Anticancer Activity

Cellular ultrastructural studies and biological effects of copper complexes of phenanthroline derivatives

Design, synthesis and structure of a trinuclear copper(II) complex having Cu3OH core with regard to aspects of antiproliferative activity and magnetic properties

Synthesis and Structure of a New Ternary Monocopper(ii) Complex Containing Mixed Ligands of 2,2′‐diamino‐4,4′‐bithiazole and Picrate: in Vitro Anticancer Activity, Molecular Docking and Reactivity Towards DNA

Synthesis and Crystal Structure of a New Copper(ii) Complex with N,N′-(4,4′-bithiazole-2,2′-diyl)diacetimidamide As Ligand: Molecular Docking, DNA-binding and Cytotoxicity Activity Studies

Synthesis and structure of a new tetracopper(II) complex bridged both by oxamido and phenolato groups: Cytotoxic activity, and reactivity towards DNA and BSA

Synthesis, crystal structure and anticancer activity of a novel ternary copper(II) complex with Schiff base derived from 2-amino-4-fluorobenzoic acid and salicylaldehyde

Synthesis And Structure Of New Dicopper(Ii) Complexes Bridged By Asymmetric N, N '-Bis( Substituted) Oxamides: In Vitro Anticancer Activity And Molecular Docking Studies Based On Bio-Macromolecular Interaction

Synthesis, Antiproliferative Activity and Mechanism of Copper(ii)-Thiosemicarbazone Complexes As Potential Anticancer and Antimicrobial Agents

New copper (II) complexes bearing tryptophan‐based Schiff bases and 2,2′‐bipyridine: Crystal structures, DNA/BSA interactions and antiproliferative activities

Synthesis and Crystal Structure of Binuclear Copper(II) Complex Bridged by N‐(2‐Hydroxyphenyl)‐N′‐[3‐(diethylamino)propyl]oxamide: in Vitro Anticancer Activity and Reactivity Toward DNA and Protein

Copper (II) complexes based bis(pyrazolyl)borate derivatives as efficient anticancer agents: synthesis, characterization, X-ray structure, cytotoxicity, molecular docking and QSAR studies

Copper(II) complexes incorporated with 2,2-bipyridyl and 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol derivatives: In-vitro interaction with DNA/BSA, DFT, molecular docking and cytotoxicity

Effect of the hydroxamate group in the antitumoral activity and toxicity toward normal cells of new copper(II) complexes

Exploring the BSA-, DNA-binding, cytotoxicity and cell cycle evaluation of ternary copper(II)/diimine complexes with N,N-dibenzyl-N'-benzoylthiourea as promising metallodrug candidates

Copper(Ii) Coordination Compounds Based On Bis-Hydrazones Of 2,6-Diacetylpyridine: Synthesis, Structure, And Cytotoxic Activity

Synthesis and Crystal Structure of New Dicopper(Ii) Complexes Having Asymmetric N,N '-Bis(substituted)oxamides with Dna/Protein Binding Ability: in Vitro Anticancer Activity and Molecular Docking Studies